Back to Search Start Over

Botulinum toxin type A for genitofemoral neuralgia: A case report.

Authors :
Tereshko Y
Enrico B
Christian L
Dal Bello S
Merlino G
Gigli GL
Valente M
Source :
Frontiers in neurology [Front Neurol] 2023 Jul 03; Vol. 14, pp. 1228098. Date of Electronic Publication: 2023 Jul 03 (Print Publication: 2023).
Publication Year :
2023

Abstract

Genitofemoral neuralgia is an uncommon pain disorder that could be resistant to conventional treatment. A 78-year-old woman with refractory right genitofemoral neuralgia was treated with BoNT/A subcutaneous injections; the treatment was performed three times with significant pain improvement, although temporary, and without adverse events. BoNT/A may be a promising alternative intervention in the setting of genitofemoral neuralgia refractory to oral and/or topical treatment.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2023 Tereshko, Enrico, Christian, Dal Bello, Merlino, Gigli and Valente.)

Details

Language :
English
ISSN :
1664-2295
Volume :
14
Database :
MEDLINE
Journal :
Frontiers in neurology
Publication Type :
Academic Journal
Accession number :
37465764
Full Text :
https://doi.org/10.3389/fneur.2023.1228098